Split (1)

train · 3.45k rows

pbs_code stringclasses 390 values	drug stringclasses 18 values	brand stringclasses 32 values	formulation stringclasses 38 values	indication stringclasses 8 values	treatment_phase stringclasses 57 values	streamlined_code float64 9.19k 16.9k ⌀	online_application bool 2 classes	authority_method stringclasses 2 values	hospital_type stringclasses 3 values	maximum_prescribable_pack float64 1 5	maximum_quantity_units float64 1 180	schedule_code stringdate 2025-07-01 00:00:00 2025-08-01 00:00:00	schedule_year int64 2.03k 2.03k	schedule_month stringclasses 2 values
9663N	Adalimumab	Hyrimoz	Injection 40 mg in 0.8 mL pre-filled pen	juvenile idiopathic arthritis	Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months) - balance of supply	null	true	AUTHORITY_REQUIRED	Public	1	2	2025-08	2,025	AUGUST
9663N	Adalimumab	Hadlima	Injection 40 mg in 0.8 mL pre-filled pen	juvenile idiopathic arthritis	Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months) - balance of supply	null	true	AUTHORITY_REQUIRED	Public	1	2	2025-08	2,025	AUGUST
9663N	Adalimumab	Amgevita	Injection 40 mg in 0.8 mL pre-filled pen	juvenile idiopathic arthritis	Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months) - balance of supply	null	true	AUTHORITY_REQUIRED	Public	1	2	2025-08	2,025	AUGUST
9663N	Adalimumab	Abrilada	Injection 40 mg in 0.8 mL pre-filled pen	juvenile idiopathic arthritis	Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months) - balance of supply	null	true	AUTHORITY_REQUIRED	Public	1	2	2025-08	2,025	AUGUST
9671B	Tocilizumab	Actemra	Concentrate for injection 80 mg in 4 mL	rheumatoid arthritis	Initial treatment - Initial 1 (new patient)	null	false	AUTHORITY_REQUIRED	Private	1	1	2025-08	2,025	AUGUST
9671B	Tocilizumab	Actemra	Concentrate for injection 80 mg in 4 mL	rheumatoid arthritis	Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months)	null	false	AUTHORITY_REQUIRED	Private	1	1	2025-08	2,025	AUGUST
9671B	Tocilizumab	Actemra	Concentrate for injection 80 mg in 4 mL	rheumatoid arthritis	Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months)	null	false	AUTHORITY_REQUIRED	Private	1	1	2025-08	2,025	AUGUST
9671B	Tocilizumab	Actemra	Concentrate for injection 80 mg in 4 mL	rheumatoid arthritis	Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) - balance of supply	null	true	AUTHORITY_REQUIRED	Private	1	1	2025-08	2,025	AUGUST
9671B	Tocilizumab	Actemra	Concentrate for injection 80 mg in 4 mL	rheumatoid arthritis	First continuing treatment	null	false	AUTHORITY_REQUIRED	Private	1	1	2025-08	2,025	AUGUST
9671B	Tocilizumab	Actemra	Concentrate for injection 80 mg in 4 mL	rheumatoid arthritis	First continuing treatment - balance of supply	null	true	AUTHORITY_REQUIRED	Private	1	1	2025-08	2,025	AUGUST
9672C	Tocilizumab	Actemra	Concentrate for injection 200 mg in 10 mL	rheumatoid arthritis	Initial treatment - Initial 1 (new patient)	null	false	AUTHORITY_REQUIRED	Private	1	1	2025-08	2,025	AUGUST
9672C	Tocilizumab	Actemra	Concentrate for injection 200 mg in 10 mL	rheumatoid arthritis	Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months)	null	false	AUTHORITY_REQUIRED	Private	1	1	2025-08	2,025	AUGUST
9672C	Tocilizumab	Actemra	Concentrate for injection 200 mg in 10 mL	rheumatoid arthritis	Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months)	null	false	AUTHORITY_REQUIRED	Private	1	1	2025-08	2,025	AUGUST
9672C	Tocilizumab	Actemra	Concentrate for injection 200 mg in 10 mL	rheumatoid arthritis	Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) - balance of supply	null	true	AUTHORITY_REQUIRED	Private	1	1	2025-08	2,025	AUGUST
9672C	Tocilizumab	Actemra	Concentrate for injection 200 mg in 10 mL	rheumatoid arthritis	First continuing treatment	null	false	AUTHORITY_REQUIRED	Private	1	1	2025-08	2,025	AUGUST
9672C	Tocilizumab	Actemra	Concentrate for injection 200 mg in 10 mL	rheumatoid arthritis	First continuing treatment - balance of supply	null	true	AUTHORITY_REQUIRED	Private	1	1	2025-08	2,025	AUGUST
9673D	Tocilizumab	Actemra	Concentrate for injection 400 mg in 20 mL	rheumatoid arthritis	Initial treatment - Initial 1 (new patient)	null	false	AUTHORITY_REQUIRED	Private	1	1	2025-08	2,025	AUGUST
9673D	Tocilizumab	Actemra	Concentrate for injection 400 mg in 20 mL	rheumatoid arthritis	Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months)	null	false	AUTHORITY_REQUIRED	Private	1	1	2025-08	2,025	AUGUST
9673D	Tocilizumab	Actemra	Concentrate for injection 400 mg in 20 mL	rheumatoid arthritis	Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months)	null	false	AUTHORITY_REQUIRED	Private	1	1	2025-08	2,025	AUGUST
9673D	Tocilizumab	Actemra	Concentrate for injection 400 mg in 20 mL	rheumatoid arthritis	Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) - balance of supply	null	true	AUTHORITY_REQUIRED	Private	1	1	2025-08	2,025	AUGUST
9673D	Tocilizumab	Actemra	Concentrate for injection 400 mg in 20 mL	rheumatoid arthritis	First continuing treatment	null	false	AUTHORITY_REQUIRED	Private	1	1	2025-08	2,025	AUGUST
9673D	Tocilizumab	Actemra	Concentrate for injection 400 mg in 20 mL	rheumatoid arthritis	First continuing treatment - balance of supply	null	true	AUTHORITY_REQUIRED	Private	1	1	2025-08	2,025	AUGUST
9679K	Adalimumab	Hadlima	Injection 40 mg in 0.8 mL pre-filled syringe	juvenile idiopathic arthritis	Initial treatment - Initial 1 (new patient)	null	true	AUTHORITY_REQUIRED	Private	1	2	2025-08	2,025	AUGUST
9679K	Adalimumab	Amgevita	Injection 40 mg in 0.8 mL pre-filled syringe	juvenile idiopathic arthritis	Initial treatment - Initial 1 (new patient)	null	true	AUTHORITY_REQUIRED	Private	1	2	2025-08	2,025	AUGUST
9679K	Adalimumab	Hyrimoz	Injection 40 mg in 0.8 mL pre-filled syringe	juvenile idiopathic arthritis	Initial treatment - Initial 1 (new patient)	null	true	AUTHORITY_REQUIRED	Private	1	2	2025-08	2,025	AUGUST
9679K	Adalimumab	Abrilada	Injection 40 mg in 0.8 mL pre-filled syringe	juvenile idiopathic arthritis	Initial treatment - Initial 1 (new patient)	null	true	AUTHORITY_REQUIRED	Private	1	2	2025-08	2,025	AUGUST
9679K	Adalimumab	Hadlima	Injection 40 mg in 0.8 mL pre-filled syringe	juvenile idiopathic arthritis	Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months)	null	true	AUTHORITY_REQUIRED	Private	1	2	2025-08	2,025	AUGUST
9679K	Adalimumab	Amgevita	Injection 40 mg in 0.8 mL pre-filled syringe	juvenile idiopathic arthritis	Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months)	null	true	AUTHORITY_REQUIRED	Private	1	2	2025-08	2,025	AUGUST
9679K	Adalimumab	Hyrimoz	Injection 40 mg in 0.8 mL pre-filled syringe	juvenile idiopathic arthritis	Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months)	null	true	AUTHORITY_REQUIRED	Private	1	2	2025-08	2,025	AUGUST
9679K	Adalimumab	Abrilada	Injection 40 mg in 0.8 mL pre-filled syringe	juvenile idiopathic arthritis	Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months)	null	true	AUTHORITY_REQUIRED	Private	1	2	2025-08	2,025	AUGUST
9679K	Adalimumab	Hadlima	Injection 40 mg in 0.8 mL pre-filled syringe	juvenile idiopathic arthritis	Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months)	null	true	AUTHORITY_REQUIRED	Private	1	2	2025-08	2,025	AUGUST
9679K	Adalimumab	Amgevita	Injection 40 mg in 0.8 mL pre-filled syringe	juvenile idiopathic arthritis	Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months)	null	true	AUTHORITY_REQUIRED	Private	1	2	2025-08	2,025	AUGUST
9679K	Adalimumab	Hyrimoz	Injection 40 mg in 0.8 mL pre-filled syringe	juvenile idiopathic arthritis	Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months)	null	true	AUTHORITY_REQUIRED	Private	1	2	2025-08	2,025	AUGUST
9679K	Adalimumab	Abrilada	Injection 40 mg in 0.8 mL pre-filled syringe	juvenile idiopathic arthritis	Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months)	null	true	AUTHORITY_REQUIRED	Private	1	2	2025-08	2,025	AUGUST
9679K	Adalimumab	Hadlima	Injection 40 mg in 0.8 mL pre-filled syringe	juvenile idiopathic arthritis	Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months) - balance of supply	null	true	AUTHORITY_REQUIRED	Private	1	2	2025-08	2,025	AUGUST
9679K	Adalimumab	Amgevita	Injection 40 mg in 0.8 mL pre-filled syringe	juvenile idiopathic arthritis	Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months) - balance of supply	null	true	AUTHORITY_REQUIRED	Private	1	2	2025-08	2,025	AUGUST
9679K	Adalimumab	Hyrimoz	Injection 40 mg in 0.8 mL pre-filled syringe	juvenile idiopathic arthritis	Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months) - balance of supply	null	true	AUTHORITY_REQUIRED	Private	1	2	2025-08	2,025	AUGUST
9679K	Adalimumab	Abrilada	Injection 40 mg in 0.8 mL pre-filled syringe	juvenile idiopathic arthritis	Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months) - balance of supply	null	true	AUTHORITY_REQUIRED	Private	1	2	2025-08	2,025	AUGUST
9680L	Adalimumab	Hyrimoz	Injection 40 mg in 0.8 mL pre-filled pen	juvenile idiopathic arthritis	Initial treatment - Initial 1 (new patient)	null	true	AUTHORITY_REQUIRED	Private	1	2	2025-08	2,025	AUGUST
9680L	Adalimumab	Hadlima	Injection 40 mg in 0.8 mL pre-filled pen	juvenile idiopathic arthritis	Initial treatment - Initial 1 (new patient)	null	true	AUTHORITY_REQUIRED	Private	1	2	2025-08	2,025	AUGUST
9680L	Adalimumab	Amgevita	Injection 40 mg in 0.8 mL pre-filled pen	juvenile idiopathic arthritis	Initial treatment - Initial 1 (new patient)	null	true	AUTHORITY_REQUIRED	Private	1	2	2025-08	2,025	AUGUST
9680L	Adalimumab	Abrilada	Injection 40 mg in 0.8 mL pre-filled pen	juvenile idiopathic arthritis	Initial treatment - Initial 1 (new patient)	null	true	AUTHORITY_REQUIRED	Private	1	2	2025-08	2,025	AUGUST
9680L	Adalimumab	Hyrimoz	Injection 40 mg in 0.8 mL pre-filled pen	juvenile idiopathic arthritis	Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months)	null	true	AUTHORITY_REQUIRED	Private	1	2	2025-08	2,025	AUGUST
9680L	Adalimumab	Hadlima	Injection 40 mg in 0.8 mL pre-filled pen	juvenile idiopathic arthritis	Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months)	null	true	AUTHORITY_REQUIRED	Private	1	2	2025-08	2,025	AUGUST
9680L	Adalimumab	Amgevita	Injection 40 mg in 0.8 mL pre-filled pen	juvenile idiopathic arthritis	Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months)	null	true	AUTHORITY_REQUIRED	Private	1	2	2025-08	2,025	AUGUST
9680L	Adalimumab	Abrilada	Injection 40 mg in 0.8 mL pre-filled pen	juvenile idiopathic arthritis	Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months)	null	true	AUTHORITY_REQUIRED	Private	1	2	2025-08	2,025	AUGUST
9680L	Adalimumab	Hyrimoz	Injection 40 mg in 0.8 mL pre-filled pen	juvenile idiopathic arthritis	Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months)	null	true	AUTHORITY_REQUIRED	Private	1	2	2025-08	2,025	AUGUST
9680L	Adalimumab	Hadlima	Injection 40 mg in 0.8 mL pre-filled pen	juvenile idiopathic arthritis	Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months)	null	true	AUTHORITY_REQUIRED	Private	1	2	2025-08	2,025	AUGUST
9680L	Adalimumab	Amgevita	Injection 40 mg in 0.8 mL pre-filled pen	juvenile idiopathic arthritis	Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months)	null	true	AUTHORITY_REQUIRED	Private	1	2	2025-08	2,025	AUGUST
9680L	Adalimumab	Abrilada	Injection 40 mg in 0.8 mL pre-filled pen	juvenile idiopathic arthritis	Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months)	null	true	AUTHORITY_REQUIRED	Private	1	2	2025-08	2,025	AUGUST
9680L	Adalimumab	Hyrimoz	Injection 40 mg in 0.8 mL pre-filled pen	juvenile idiopathic arthritis	Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months) - balance of supply	null	true	AUTHORITY_REQUIRED	Private	1	2	2025-08	2,025	AUGUST
9680L	Adalimumab	Hadlima	Injection 40 mg in 0.8 mL pre-filled pen	juvenile idiopathic arthritis	Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months) - balance of supply	null	true	AUTHORITY_REQUIRED	Private	1	2	2025-08	2,025	AUGUST
9680L	Adalimumab	Amgevita	Injection 40 mg in 0.8 mL pre-filled pen	juvenile idiopathic arthritis	Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months) - balance of supply	null	true	AUTHORITY_REQUIRED	Private	1	2	2025-08	2,025	AUGUST
9680L	Adalimumab	Abrilada	Injection 40 mg in 0.8 mL pre-filled pen	juvenile idiopathic arthritis	Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months) - balance of supply	null	true	AUTHORITY_REQUIRED	Private	1	2	2025-08	2,025	AUGUST

Subsets and Splits

No community queries yet

The top public SQL queries from the community will appear here once available.